Skip to main content
letter
. 2020 Jun 1;201(11):1441–1443. doi: 10.1164/rccm.202001-0093LE

Figure 1.

Figure 1.

(A and B) Serial measurements of peripheral blood eosinophil count (A) and peak expiratory flow rate (B, prebronchodilator [red] and post-bronchodilator [blue]). The vertical dashed line indicates the time of benralizumab administration. The vertical solid line indicates the time of hospital discharge.